Robert E. Shiel

Prof. Dr. Robert E. Shiel


Research Focus & Metrics

Academic Career Length

20Years (2007-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
16 September 2007 in Veterinary Clinical Pathology
Verified
Journal Article
Closed access
PDF file
RSRobert E. Shiel
Robert E. Shiel
SBSheila F. Brennan
Sheila F. Brennan
LOLaurie G. O'Rourke
Laurie G. O'Rourke
MMMaureen McCullough
Maureen McCullough
CMCarmel T. Mooney
Carmel T. Mooney

1 February 2010 in Journal of the American Veterinary Medical Association
Verified
Journal Article
Closed access
RSRobert E. Shiel
Robert E. Shiel
MSMaryDee Sist
MaryDee Sist
RNRaymond F. Nachreiner
Raymond F. Nachreiner
CEClaire P. Ehrlich
Claire P. Ehrlich
CMCarmel T. Mooney
Carmel T. Mooney
Objective—To assess use of serum thyroid hormone concentrations by veterinarians to diagnose hypothyroidism in sighthounds and to evaluate serum thyroid hormone concentrations in healthy Salukis. Design—Retrospective case series and cross-sectional study. Animals—398 sighthounds of various breeds with a diagnosis of hypothyroidism and 283 healthy Salukis. Procedures—Pretreatment thyroid hormone assay results from sighthounds subsequently classified as hypothyroid by practitioners were retrieved from a laboratory database. In healthy Salukis, serum concentrations of total thyroxine (T4), free T4, total triiodothyronine (T3), free T3, and thyroid-stimulating hormone (TSH) and antibodies against thyroglobulin and thyroid hormones were assayed. Results—Records indicated hypothyroidism had been diagnosed in 303 (76.1%) sight-hounds on the basis of low serum thyroid hormone concentrations alone and in 30 (7.5%) others despite all thyroid hormone indices being within reference limits. Only 65 (16.3%) dogs had a high TSH concentration or positive thyroglobulin autoantibody result to support the diagnosis. In healthy Salukis, median (reference limits) serum concentrations of total T4, free T4, total T3, free T3, and TSH were 13.0 nmol/L (2.8 to 40.0 nmol/L), 12.0 pmol/L (2.0 to 30.3 pmol/L), 1.0 nmol/L (0.4 to 2.1 nmol/L), 4.0 pmol/L (1.6 to 7.7 pmol/L), and 0.18 ng/mL (0 to 0.86 ng/mL), respectively. Conclusions and Clinical Relevance—Diagnosis of hypothyroidism by practitioners was most often made without adequate supportive laboratory evidence. Thyroid hormone values in healthy Salukis differed markedly from standard reference limits for some, but not all, thyroid hormone indices. Breed-specific reference limits should be used when interpreting thyroid hormone profiles of sighthounds.

14 February 2022 in Canine Medicine and Genetics
Verified
Journal Article
Open access
PDF file
RSRobert E. Shiel
Robert E. Shiel
CMCarmel T. Mooney
Carmel T. Mooney
The year 2021 marked the centenary of the isolation of a therapeutic form of insulin and its successful use in dogs. This was a landmark moment that subsequently and rapidly led to the commercial manufacture of insulin for use in humans. The impact of insulin was almost miraculous as those destined to die from their diabetes mellitus returned to life. Over the past 100 years, insulin formulations have been modified to attempt to provide a predictable and prolonged duration of action while avoiding the development of hypoglycaemia. This has led to an ever-growing variety of insulin types in human medicine, many of which have subsequently been used in dogs. The purpose of this review article is to provide an overview of available insulin types and their application to the chronic management of canine diabetes mellitus.

15 January 2018 in Irish Veterinary Journal
Verified
Journal Article
Open access
PDF file
LBLaura Bree
Laura Bree
BGBarbara A. Gallagher
Barbara A. Gallagher
RSRobert E. Shiel
Robert E. Shiel
CMCarmel Mooney
Carmel Mooney
Hyperthyroidism is common in older cats. Prevalence varies geographically, but is anecdotally considered low in Ireland. The aim of this study was to document prevalence of hyperthyroidism in older cats in the greater Dublin area of Ireland and to assess environmental and clinical associations for development and identification of the disease. Primary-care veterinary practices were requested to select cats aged 10 years or older where blood sampling was being performed for health screening or clinical investigations. Surplus serum/plasma samples were submitted to University College Dublin Diagnostic Endocrine Laboratory for total thyroxine (T4) measurement. Cats were classified as hyperthyroid, equivocal or euthyroid based on a total T4 concentration (reference interval, 15–60 nmol/L), of >60 nmol/L, 30–60 nmol/L or <30 nmol/L, respectively. Simultaneous free T4 or repeat (after 4–6 weeks) total T4 measurement was recommended in all equivocal cases. Animals receiving treatment for hyperthyroidism were excluded. A questionnaire completed by the client and veterinarian detailing historical and physical information was also required. Associations between categorical variables were analysed by Chi-square or Fisher’s exact test and odds ratio (OR) calculated. A P value of <0.05 was considered statistically significant. Samples were submitted from 507 cats including 107 (21.1%) hyperthyroid, 54 (10.6%) equivocal and 346 (68.2%) euthyroid. The presence of goitre (P < 0.0001), tachypnoea (P = 0.0378), tachycardia (P = 0.002), polyphagia (P = 0.0003) and weight loss (P < 0.0001) were significantly associated with hyperthyroidism. Cats with goitre were more likely to be diagnosed as hyperthyroid [OR 2.85, (95% CI 1.75–4.62] compared to those without. However, goitre was only palpated in 40 of 102 (39.2%) hyperthyroid cats. Increasing age was the only significant (P < 0.002) risk factor for development of hyperthyroidism. A relationship between hyperthyroidism and sex, breed, lifestyle, parasite control, vaccination status or feeding habits was not identified. Hyperthyroidism is not uncommon in Irish cats. Age was the only significant risk factor for its development. The high proportion of hyperthyroid cats without palpable goitre (> 60%) may reflect failure to detect goitre and account for the perceived low prevalence of this condition in Ireland.

1 July 2007 in Veterinary Clinics of North America: Small Animal Practice
Verified
Journal Article
Closed access
RSRobert E. Shiel
Robert E. Shiel
CMCarmel T. Mooney
Carmel T. Mooney

1 February 2007 in Irish Veterinary Journal
Verified
Journal Article
Open access
PDF file
RSRobert E. Shiel
Robert E. Shiel
EAEls Acke
Els Acke
APAntonella Puggioni
Antonella Puggioni
JCJoseph P Cassidy
Joseph P Cassidy
CMCarmel T Mooney
Carmel T Mooney
: A nine-year-old male entire Labrador was diagnosed with pituitary dependent hyperadrenocorticism. Following seven months of successful mitotane therapy, the dog presented with marked weight gain, seborrhoea and alopecia. Routine clinicopathological analyses revealed marked hypercholesterolaemia. Serum total and free thyroxine (T4) concentrations were below their respective reference ranges. Serum thyroid stimulating hormone (cTSH) concentration was within reference range. TSH and thyrotropin releasing hormone (TRH) response tests revealed adequate stimulation of total T4 in both, and cTSH in the latter test. Magnetic resonance imaging revealed a mass arising from the pituitary fossa, with suprasellar extension. A diagnosis of tertiary hypothyroidism was made. Following four weeks of levothyroxine therapy, circulating cholesterol concentration had declined, weight loss had ensued and dermatological abnormalities had improved. Euthanasia was performed four months later due to the development of neurological signs. A highly infiltrative pituitary adenoma, with effacement of the overlying hypothalamus was identified on post mortem examination. Tertiary hypothyroidism has not been previously reported in dogs.